Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saniona ABCHIX:SANIOS 49 EV-to-OCF is 4.78 as of Aug. 18, 2026. GuruFocus rates CHIX:SANIOS with a GF Score™ of 49/100. The stock has 3 warning signs investors should review. Among 1,409 Biotechnology companies, Saniona AB ranks worse than 80.7% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Saniona AB's Enterprise Value is kr1,219.6 Mil.
Saniona AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr255.2 Mil. Therefore, Saniona AB's EV-to-OCF for today is 4.78.
The historical rank and industry rank for Saniona AB's EV-to-OCF or its related term are showing as below:
CHIX:SANIOs'
s EV-to-OCF Range Over the Past 10 Years
Min: -328.46 Med: -3.45 Max: 249.9
Current: 4.89
During the past 13 years, the highest EV-to-OCF of Saniona AB was 249.90. The lowest was -328.46. And the median was -3.45.
CHIX:SANIOs's EV-to-OCF is ranked worse than 80.7% of 1409
companies
in the Biotechnology industry
Industry Median: -3.6
vs CHIX:SANIOs: 4.89
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Saniona AB's share price for today is kr12.94.
Saniona AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Saniona AB EV-to-OCF Related Terms
Saniona AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Saniona AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SANIOS vs VRTX, REGN, RVMD: EV-to-OCF Comparison
For the Biotechnology subindustry, Saniona AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saniona AB EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Saniona AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Saniona AB's EV-to-OCF falls into.
Saniona AB's current Enterprise Value is kr1,219.6 Mil.
Saniona AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr255.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saniona AB (CHIX:SANIOS) has a EV-to-OCF of 4.78 as of Aug. 18, 2026. According to the industry distribution chart, Saniona AB ranks #1137 out of 1409 companies in the Biotechnology industry, placing it in the top 80.7%.
Is Saniona AB's EV-to-OCF too high?
Saniona AB's current EV-to-OCF is 4.78. Based on the distribution chart, Saniona AB ranks #1137 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Saniona AB has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Saniona AB ranks #1137 out of 1409 companies for EV-to-OCF. This places Saniona AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Saniona AB's current EV-to-OCF is 4.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Saniona AB (CHIX:SANIOS) has a current EV-to-OCF of 4.78. The current EV-to-OCF is 4.78. Saniona AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Saniona AB (CHIX:SANIOS), the current EV-to-OCF is 4.78 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
49GF Score
Get the complete analysis for CHIX:SANIOS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SANIOS has been successfully added to your 
